A medical device can have the required regulatory permissions, strong clinical credentials, and an experienced distributor—and still struggle to secure its first hospital purchase.
The gap often lies in the decisions that follow regulatory readiness. A clinician needs confidence in the technology. A department needs a reason to change its workflow. Procurement needs an acceptable supplier and commercial proposal. Finance needs a credible investment case. Biomedical engineering needs confidence in installation, maintenance, and uptime.
Each decision addresses a different risk. Progress depends on resolving them together.
For companies planning healthcare market entry in India, the commercial challenge is therefore broader than securing approval and building a sales pipeline. It is to establish why a specific hospital should introduce the technology, how it will pay for it, and what will make the product usable after installation.
A practical market entry strategy connects regulatory readiness with clinical evidence, departmental sponsorship, procurement requirements, funding, training, and service delivery.
Regulatory readiness opens the door; the hospital still needs a purchase case
India’s medical devices framework sits under the Drugs and Cosmetics Act, 1940, and the Medical Devices Rules, 2017. The applicable regulatory requirements depend on the product, classification, intended use, and activities involved. Commercial teams should establish the requirements for their specific device before making launch commitments. [1]
That regulatory foundation answers an essential question: under what conditions can the product enter the market?
The hospital must then answer another: should we introduce it here?
That decision depends on the hospital’s patient mix, clinical priorities, existing equipment, available staff, infrastructure, and financial position. A device that offers clear value in a high-volume specialty centre may have a weak business case in a hospital with limited eligible patients.
Successful medical device commercialisation in India starts by defining the adoption case at the hospital level:
- Which clinical or operational problem does the product address?
- How significant is that problem for the target department?
- What evidence supports the proposed benefit?
- What will staff need to change?
- Who owns the budget?
- Can the supplier support reliable use throughout the product’s life?
These questions should shape account selection before the company commits substantial resources to demonstrations or evaluations.
The seven decisions between readiness and adoption
Hospital purchases rarely follow a perfectly linear sequence. Clinical, commercial, and technical reviews may run in parallel, and an unresolved issue can send a proposal back for reconsideration.
The following framework provides a practical way to manage that process. Roles and approval structures vary by institution.
| Decision stage | Hospital’s central question | What the MedTech company should prepare |
|---|---|---|
| Clinical evaluation | Does the technology address a relevant need safely and effectively? | Evidence aligned with intended use, comparative information, and a defined evaluation plan |
| Departmental sponsorship | Will the department support its introduction and routine use? | A clinical sponsor, user feedback, workflow assessment, and implementation owner |
| Procurement review | Can we purchase from this supplier on acceptable terms? | Regulatory documentation, vendor credentials, specifications, pricing, and supply commitments |
| Budget approval | Is this an affordable and justified use of funds? | Total ownership cost, utilisation assumptions, funding options, and a realistic economic case |
| Installation and acceptance | Can the technology operate reliably in this facility? | Site assessment, infrastructure requirements, commissioning plan, and acceptance criteria |
| Training and go-live | Can intended users operate it competently across shifts? | Role-specific training, competency checks, operating procedures, and launch support |
| Servicing and continued use | Can we sustain performance and resolve failures? | Maintenance arrangements, spare-parts access, response commitments, and escalation procedures |
A sales forecast becomes more useful when it records the status of these decisions. “The doctor liked the demonstration” is encouraging, but it does not establish budget availability, procurement acceptance, or readiness to install.
1. Clinical evaluation: establish what the hospital needs to learn
A demonstration shows how a product works. A structured evaluation helps a hospital decide whether it is useful in its own setting.
Before starting, agree on the problem being assessed, the relevant comparator, participating users, evaluation period, and success criteria.
Depending on the technology, useful measures might include diagnostic performance, procedure time, repeat tests, usability, technical failures, or staff time per case. Measures should match the product’s intended use and the claims being assessed.
For example, if a device promises faster turnaround, the evaluation should examine the relevant end-to-end workflow. A faster instrument step may deliver little operational benefit if specimen transport or result approval remains the main bottleneck.
The evaluation should also have a decision attached to it. Who will review the findings? What result would justify a purchase proposal? What additional questions could prevent approval?
An evaluation should not be treated as a way around regulatory requirements. Clinical investigations of investigational devices are subject to the applicable permissions and ethics requirements under the Medical Devices Rules. The correct route depends on the nature of the activity. [2]
2. Departmental sponsorship: build support beyond one enthusiastic clinician
A respected clinician can create access and establish clinical relevance. Sustained MedTech hospital adoption, however, requires support from the people responsible for daily use.
The department head may sponsor the proposal. Nurses, technicians, and other clinicians may determine whether the technology fits routine practice. Biomedical engineering may identify technical constraints. An administrator may need to coordinate implementation.
The company should establish who will:
- Own the clinical case.
- Coordinate the evaluation.
- Consolidate user feedback.
- Support the internal purchase proposal.
- Take responsibility for implementation after approval.
This reduces dependence on one individual and makes the proposal easier for the hospital to assess.
Clinician support should rest on evidence, clinical relevance, and a workable implementation plan. An endorsement alone cannot resolve operational or financial objections.
3. Procurement review: make the proposal easy to assess
Hospital procurement in India involves more than price negotiation. Depending on the institution and purchase, the review may cover supplier eligibility, technical compliance, documentation, commercial terms, delivery, warranty, consumables, and maintenance.
A complete submission reduces avoidable clarification cycles.
Prepare a structured procurement pack containing the applicable regulatory documents, product specifications, configuration details, quotation, warranty scope, installation responsibilities, training provision, and service terms.
Make exclusions explicit. A quotation that omits essential accessories, software licences, freight, site preparation, or required consumables can lose credibility when the full cost emerges later.
Where a distributor is involved, define the responsibilities of the manufacturer and channel partner. The hospital should know who handles applications support, complaints, repairs, replacement parts, and contractual escalation.
4. Budget approval: connect value to an identifiable source of funds
A clinically attractive product can stall because the budget owner has not been identified.
Establish whether the purchase requires capital expenditure, fits an operating budget, replaces an existing expense, or depends on funding for a new service line. Ask when approval can occur and what information the decision-maker requires.
Commercial options may include an outright purchase, lease, rental, or usage-linked arrangement where appropriate. Each creates different obligations and risks.
A low initial payment can conceal minimum purchase commitments, long contract terms, or expensive consumables. The hospital needs visibility into the full financial commitment.
For the supplier, commercial flexibility should support sustainable delivery. A contract that leaves insufficient resources for training, servicing, or working capital can undermine the adoption it was intended to accelerate.
5. Installation: resolve site requirements before delivery
Installation problems often begin before the purchase order, when site requirements remain untested.
Depending on the technology, readiness may involve electrical supply, backup power, space, ventilation, water, medical gases, network access, infection-control arrangements, or integration with existing systems.
Conduct a site assessment early enough to identify additional costs and responsibilities.
Agree on who completes preparatory work, who verifies readiness, and what constitutes successful installation and acceptance. Delivery, commissioning, acceptance, and payment milestones should be clear to both parties.
6. Training: prepare for routine use across shifts
Training should cover the people who will actually use and support the product.
A single launch session may leave gaps across shifts, departments, or staff categories. Build a plan for primary users, backup users, supervisors, and relevant technical staff.
Include routine operation, troubleshooting, cleaning or reprocessing where applicable, escalation, and refresher training. Use competency checks appropriate to the device and its risks.
The practical test is whether the hospital can continue using the technology competently when the supplier’s launch team leaves.
7. Servicing: make reliability part of the purchase proposition
Service capability influences the credibility of the entire offer. Hospitals need to understand what happens when a device fails, a consumable is unavailable, or a trained operator leaves.
NHSRC’s Biomedical Equipment Management and Maintenance Programme explicitly links equipment maintenance with uptime in public health facilities, reinforcing the operational importance of keeping equipment functional. [3]
Translate service promises into clear commitments: coverage locations, response times, preventive maintenance, calibration where relevant, spare-parts availability, exclusions, and escalation ownership.
Distinguish a response commitment from a restoration commitment. Acknowledging a breakdown quickly is useful; restoring clinical capacity is the outcome the hospital needs.
Private hospital groups, independent hospitals, and public buyers require different approaches
India is not a single hospital customer segment. Ownership, governance, purchasing authority, clinical focus, and funding create different routes to adoption.
The following comparison describes planning patterns rather than universal rules.
| Dimension | Private hospital groups | Independent hospitals | Public procurement |
|---|---|---|---|
| Decision structure | May combine hospital-level clinical input with regional or corporate approval | May concentrate decisions among owners, administrators, and department heads | Authority may sit with the institution, department, procurement agency, or another designated body |
| Main adoption questions | Clinical value, standardisation, economics, integration, and support across locations | Local demand, affordability, cash flow, usability, and dependable service | Eligibility, technical compliance, sanctioned funding, evaluation criteria, and contractual delivery |
| Useful entry approach | Establish a relevant reference site and clarify the route to wider approval | Build a hospital-specific case around patient volumes and operating constraints | Assess procurement requirements and bid readiness before committing resources |
| Common planning error | Assuming one successful installation guarantees group-wide adoption | Assuming fewer decision-makers guarantees a quick purchase | Assuming clinician interest can substitute for the formal purchasing process |
Private hospital groups: distinguish local success from group approval
A department may support the technology while corporate procurement or finance still requires further review.
Map both levels. Determine whether the first site can purchase independently, whether a central contract is necessary, and what evidence would support deployment elsewhere.
If expansion is part of the strategy, choose a reference hospital whose results are relevant to other sites. An unusually well-resourced flagship may produce impressive outcomes that are difficult to reproduce across the group.
Independent hospitals: build around local operating realities
An independent hospital may offer direct access to the owner or administrator, but the purchase still needs a convincing financial and operational case.
Patient volumes, existing equipment, borrowing capacity, referral patterns, and service access can materially influence the decision.
Demonstrate how the technology fits the hospital’s actual practice. Use realistic demand assumptions and show what happens if utilisation grows more slowly than expected.
Public procurement: treat the purchasing process as a core workstream
Public buyers operate under the rules applicable to their institution and jurisdiction. Central government procurement guidance should not be assumed to describe every state or hospital process.
For covered procurement, the Department of Expenditure’s Manual for Procurement of Goods, 2024 sets out technical and commercial evaluation principles and financial ranking requirements. The tender’s disclosed criteria govern how offers are assessed. A broader lifecycle-value argument cannot simply replace the specified evaluation method. [4]
Review eligibility, technical specifications, documentation, securities, delivery obligations, acceptance conditions, maintenance requirements, and payment terms before bidding.
Clinical engagement can help a company understand unmet needs through appropriate channels. It does not remove the need to meet the formal procurement requirements.
Build evidence for the decision being made
Evidence should help the hospital assess a specific claim.
A strong evidence pack combines several perspectives:
| Evidence layer | Question it should help answer |
|---|---|
| Clinical | Does the technology deliver the claimed safety and performance for its intended use? |
| Operational | Can it work effectively within this hospital’s staffing, infrastructure, and workflow? |
| Economic | Are the benefits credible relative to acquisition and ongoing costs? |
| Service | Can the supplier support reliable use over the expected life of the product? |
International studies may establish important clinical credibility. Hospitals may still need to understand how the findings apply to their patient population, staffing model, or operating conditions.
Local evaluation should address those uncertainties with an appropriate design. It should not become an open-ended demonstration or a source of claims that the data cannot support.
Keep evidence quality visible. Explain the study population, comparator, limitations, and relevance. Distinguish a measured clinical result from a projected financial benefit.
Make total ownership cost visible
The purchase price is only one component of the hospital’s commitment.
The Department of Expenditure’s procurement manual recognises total ownership and lifecycle costing as concepts that extend beyond initial acquisition to operating, maintenance, and disposal costs. [4]
For a hospital business case, assess the relevant costs over an agreed period:
Total ownership cost = acquisition + installation + training + consumables + software and integration + operation + maintenance + end-of-life costs.
Avoid double-counting costs already bundled into the contract. Where relevant, model the consequences of downtime separately and explain the assumptions.
Cost per completed case can be more informative than equipment price:
Cost per completed case = relevant costs over the assessment period ÷ completed cases over the same period.
Use a consistent time horizon and test conservative utilisation.
If the business case depends on increased throughput, ask whether the hospital has sufficient demand and whether another constraint will limit output. Time saved creates financial value only when it translates into a useful operational change, such as additional capacity, reduced overtime, or avoided expenditure.
Checklist: selecting the first hospital segment
The first customers should help the company prove a repeatable adoption model.
Before prioritising a segment, assess the following:
☐ Clinical need: Is there a specific, consequential problem the product addresses?
☐ Eligible volume: Are there enough relevant patients or procedures to support evaluation and routine use?
☐ Evidence fit: Does the available evidence support the intended application?
☐ Clinical sponsorship: Is there a credible sponsor with departmental support?
☐ User readiness: Can the hospital provide staff time for evaluation, training, and adoption?
☐ Decision access: Are the clinical, financial, procurement, and technical decision-makers identifiable?
☐ Budget route: Is there a plausible funding source and approval window?
☐ Procurement fit: Can the company meet supplier and purchasing requirements?
☐ Infrastructure: Can the site support installation without unresolved dependencies?
☐ Service coverage: Can the company deliver the promised support economically?
☐ Commercial viability: Do pricing, payment terms, and support costs produce a sustainable account?
☐ Replication potential: Will success generate relevant learning for similar hospitals?
Use the checklist to compare segments, then validate the shortlist through conversations with clinicians, procurement teams, administrators, and biomedical engineers.
The most prestigious hospital is not automatically the most useful first customer. Prioritise a setting where the need is clear, the adoption pathway is accessible, and the outcome can inform subsequent sales.
Build the GTM strategy around adoption milestones
A practical healthcare GTM strategy in India should track movement through hospital decisions.
Useful milestones include a confirmed need, identified sponsor, agreed evaluation, completed review, accepted business case, available budget, procurement clearance, installation, trained users, and sustained utilisation.
These milestones expose where the commercial process is weakening.
Repeated evaluations without purchase decisions may indicate poor account qualification or unclear success criteria. Orders followed by low usage may point to workflow or training gaps. Strong demand combined with recurring downtime may reveal a service-capacity constraint.
For MedTech leaders, this is the central execution task: align the clinical promise, hospital economics, and delivery model before scaling account acquisition.
The GreyRadius perspective
Healthcare market entry succeeds when strategy reflects how hospitals make decisions and how staff deliver care.
A useful entry plan therefore begins with primary-market validation across the people who influence adoption. It tests the clinical need, purchasing route, financial assumptions, infrastructure requirements, and service expectations within a clearly defined hospital segment.
GreyRadius’s strategy-to-execution approach connects those findings to segment selection, value proposition, channel design, and an actionable hospital adoption plan.
Planning healthcare market entry in India? Start by validating the hospital decisions your commercial model depends on.
Frequently asked questions
How do hospitals in India evaluate new medical technologies?
Hospitals may assess clinical evidence, regulatory documentation, technical suitability, workflow fit, user feedback, costs, and service capability. Depending on the product and institution, the process may include a demonstration, structured evaluation, technical review, or formal tender assessment. Evaluation criteria should reflect the intended use and the hospital’s specific need.
Who influences a hospital purchase?
Influencers can include treating clinicians, department heads, nurses, technicians, biomedical engineers, procurement teams, finance leaders, administrators, and owners or corporate management. IT and infection-control teams may also be relevant. Public purchases additionally follow the applicable committee and approval structure. The clinical sponsor, budget owner, and final approving authority may be different people.
What evidence supports medical device adoption?
Relevant evidence can include clinical studies, comparative performance data, safety information, usability findings, workflow assessments, economic analysis, and service-performance records. Evidence should support the specific intended use and claimed benefit. Local evaluation can help address uncertainties about implementation, provided it follows applicable regulatory and institutional requirements.
How should a MedTech company select its first hospital customers?
Prioritise hospitals with a clear clinical need, sufficient eligible volume, credible sponsorship, an identifiable budget route, suitable infrastructure, and service requirements the company can fulfil. Assess procurement eligibility, payment terms, and the resources required to support adoption. Choose early customers whose experience can help establish a repeatable model for similar hospitals.
Sources
[1] CDSCO — Medical Device and Diagnostics
[2] CDSCO — Medical Devices Rules 2017
[3] NHSRC — Biomedical Equipment Management and Maintenance Programme
[4] Department of Expenditure — Manual for Procurement of Goods Second Edition 2024
Read the related Indian hospital adoption case study, or contact GreyRadius to discuss your execution priorities.